Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
<http://hl7.org/fhir/EvidenceVariable/236950> a fhir:EvidenceVariable ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "236950"] ; #
fhir:meta [
fhir:versionId [ fhir:v "75" ] ;
fhir:lastUpdated [ fhir:v "2026-08-06T17:15:59.259Z"^^xsd:dateTime ] ;
fhir:profile ( [
fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment>
] )
] ; #
fhir:language [ fhir:v "en"] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: EvidenceVariable 236950</b></p><a name=\"236950\"> </a><a name=\"hc236950\"> </a><div style=\"display: inline-block; background-color: #fbffeb; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 75; Last updated: 2026-08-06 17:15:59+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-group-assignment.html\">GroupAssignment</a></p></div><p><b>ArtifactPublicationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}\">Active</span></p><p><b>url</b>: <a href=\"EvidenceVariable-236950.html\">EvidenceVariable GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA</a></p><p><b>identifier</b>: FEvIR Object Identifier/236950, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-group-assignment-85394-85798, <a href=\"http://terminology.hl7.org/7.5.0/NamingSystem-uri.html\" title=\"As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt #xD;#xA;#xD;#xA;This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: #xD;#xA;#xD;#xA;Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.#xD;#xA;#xD;#xA;This OID may also be used in CD.codeSystem.\">Uniform Resource Identifier (URI)</a>/urn:oid:2.16.840.1.113883.4.642.40.44.24.148</p><p><b>version</b>: 1.0.0-ballot3</p><p><b>name</b>: GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA</p><p><b>title</b>: GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA</p><p><b>citeAs</b>: </p><div><p>GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236950. Revised 2026-08-06. Available at: https://fevir.net/resources/EvidenceVariable/236950. Computable resource at: https://fevir.net/resources/EvidenceVariable/236950#json.</p>\n</div><p><b>status</b>: Active</p><p><b>date</b>: 2026-11-05 14:34:28+0000</p><p><b>author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href=\"http://www.hl7.org/Special/committees/dss\">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: </p><div><p>This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>\n</div><p><b>copyright</b>: </p><div><p>Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).</p>\n</div><h3>RelatesTos</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Target[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/artifact-relationship-type part-of}\">Part Of</span></td><td>MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)</td></tr></table><h3>Definitions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-handling-and-category}\">Defined in handling and category elements</span></td></tr></table><p><b>handling</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000090}\">dichotomous variable</span></p><blockquote><p><b>category</b></p><p><b>name</b>: SGLT2 inhibitors</p><p><b>value</b>: <a href=\"Group-236769.html\">Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors</a></p></blockquote><blockquote><p><b>category</b></p><p><b>name</b>: GLP-1 RA</p><p><b>value</b>: <a href=\"Group-236776.html\">Glucagon-Like Peptide-1 (GLP-1) receptor agonists</a></p></blockquote></div>"^^rdf:XMLLiteral ]
] ; #
fhir:extension ( [
fhir:url [
fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status>
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:coding ( [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/cited-artifact-status-type>
] ;
fhir:code [ fhir:v "active" ] ;
fhir:display [ fhir:v "Active" ]
] )
]
] ) ; #
fhir:url [
fhir:v "https://fevir.net/resources/EvidenceVariable/236950"^^xsd:anyURI ;
fhir:l <https://fevir.net/resources/EvidenceVariable/236950>
] ; #
fhir:identifier ( [
fhir:type [
fhir:coding ( [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/v2-0203"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/v2-0203>
] ;
fhir:code [ fhir:v "ACSN" ] ;
fhir:display [ fhir:v "Accession ID" ]
] ) ;
fhir:text [ fhir:v "FEvIR Object Identifier" ]
] ;
fhir:system [
fhir:v "https://fevir.net/FOI"^^xsd:anyURI ;
fhir:l <https://fevir.net/FOI>
] ;
fhir:value [ fhir:v "236950" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]
]
] [
fhir:type [
fhir:text [ fhir:v "FEvIR Linking Identifier" ]
] ;
fhir:system [
fhir:v "https://fevir.net/FLI"^^xsd:anyURI ;
fhir:l <https://fevir.net/FLI>
] ;
fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-group-assignment-85394-85798" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]
]
] [
fhir:system [
fhir:v "urn:ietf:rfc:3986"^^xsd:anyURI ;
fhir:l <urn:ietf:rfc:3986>
] ;
fhir:value [ fhir:v "urn:oid:2.16.840.1.113883.4.642.40.44.24.148" ]
] ) ; #
fhir:version [ fhir:v "1.0.0-ballot3"] ; #
fhir:name [ fhir:v "GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA"] ; #
fhir:title [ fhir:v "GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA"] ; #
fhir:citeAs [ fhir:v "GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236950. Revised 2026-08-06. Available at: https://fevir.net/resources/EvidenceVariable/236950. Computable resource at: https://fevir.net/resources/EvidenceVariable/236950#json."] ; #
fhir:status [ fhir:v "active"] ; #
fhir:date [ fhir:v "2026-11-05T14:34:28+00:00"^^xsd:dateTime] ; #
fhir:author ( [
fhir:name [ fhir:v "Computable Publishing®: MAGIC-to-FEvIR Converter" ]
] ) ; #
fhir:publisher [ fhir:v "HL7 International / Clinical Decision Support"] ; #
fhir:contact ( [
fhir:name [ fhir:v "HL7 International / Clinical Decision Support" ] ;
fhir:telecom ( [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "http://www.hl7.org/Special/committees/dss" ]
] )
] ) ; #
fhir:description [ fhir:v "This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide."] ; #
fhir:copyright [ fhir:v "Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."] ; #
fhir:relatesTo ( [
fhir:type [
fhir:coding ( [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/artifact-relationship-type"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/artifact-relationship-type>
] ;
fhir:code [ fhir:v "part-of" ] ;
fhir:display [ fhir:v "Part Of" ]
] )
] ;
fhir:target [
a fhir:Reference ;
fhir:type [
fhir:v "Composition"^^xsd:anyURI ;
fhir:l fhir:Composition
] ;
fhir:identifier [
fhir:type [
fhir:text [ fhir:v "FEvIR Linking Identifier" ]
] ;
fhir:system [
fhir:v "https://fevir.net/FLI"^^xsd:anyURI ;
fhir:l <https://fevir.net/FLI>
] ;
fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-conversion-report" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]
]
] ;
fhir:display [ fhir:v "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes" ]
]
] ) ; #
fhir:definition [
fhir:concept [
fhir:coding ( [
fhir:system [
fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ;
fhir:l <https://fevir.net/resources/CodeSystem/179423>
] ;
fhir:code [ fhir:v "defined-in-handling-and-category" ] ;
fhir:display [ fhir:v "Defined in handling and category elements" ]
] )
]
] ; #
fhir:handling [
fhir:coding ( [
fhir:system [
fhir:v "https://fevir.net/sevco"^^xsd:anyURI ;
fhir:l <https://fevir.net/sevco>
] ;
fhir:code [ fhir:v "STATO:0000090" ] ;
fhir:display [ fhir:v "dichotomous variable" ]
] )
] ; #
fhir:category ( [
fhir:name [ fhir:v "SGLT2 inhibitors" ] ;
fhir:value [
a fhir:Reference ;
fhir:l <http://hl7.org/fhir/Group/236769> ;
fhir:reference [ fhir:v "Group/236769" ] ;
fhir:type [
fhir:v "Group"^^xsd:anyURI ;
fhir:l fhir:Group
] ;
fhir:identifier [
fhir:type [
fhir:text [ fhir:v "FEvIR Linking Identifier" ]
] ;
fhir:system [
fhir:v "https://fevir.net/FLI"^^xsd:anyURI ;
fhir:l <https://fevir.net/FLI>
] ;
fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-intervention-85394-I-85798" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]
]
] ;
fhir:display [ fhir:v "Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors" ]
]
] [
fhir:name [ fhir:v "GLP-1 RA" ] ;
fhir:value [
a fhir:Reference ;
fhir:l <http://hl7.org/fhir/Group/236776> ;
fhir:reference [ fhir:v "Group/236776" ] ;
fhir:type [
fhir:v "Group"^^xsd:anyURI ;
fhir:l fhir:Group
] ;
fhir:identifier [
fhir:type [
fhir:text [ fhir:v "FEvIR Linking Identifier" ]
] ;
fhir:system [
fhir:v "https://fevir.net/FLI"^^xsd:anyURI ;
fhir:l <https://fevir.net/FLI>
] ;
fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-comparator-85394-C-85798" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]
]
] ;
fhir:display [ fhir:v "Glucagon-Like Peptide-1 (GLP-1) receptor agonists" ]
]
] ) . #
<http://hl7.org/fhir/Group/236769> a fhir:Group .
<http://hl7.org/fhir/Group/236776> a fhir:Group .
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-snapshot1.
Generated
2026-11-05
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change
